news
BenevolentAI becomes first AI company to appoint a Chief Medical Officer
BenevolentAI is the first AI company to have a CMO on its staff.
List view / Grid view
Informatics
news
Chronos and Aptuit partner up for addictive behaviour programmes
The companies will work together on integrated drug discovery - medicinal and computational chemistry, biology and DMPK - to optimise Chronos’ selective orexin 1 antagonists that have shown promise in treating addiction.
article
Draper and Pfizer partner on human organ-on-a-chip technology
The companies will collaborate to create unique versions of Draper’s Microphysiological Systems (MPS) technology, with the aim of creating more effective disease models...
article
Industrialising organoids for the next generation of drug discovery
New synthetic 3D gel technology for cell culture promises to unlock the potential of ‘mini-organs’ for industrial drug discovery.
news
QGel raises $12 million to grow mini-organs for drug discovery
The biomaterials company QGel has received $12 million to be used to accelerate QGel’s global expansion and broaden the company "organoids" products.
article
Tackling the spread of pathogens in transport hubs
Ilpo Kulmala, Principal Scientist at VTT Ltd, explains the role that transportation plays in the spread of infectious diseases...
news
Enhanced CRISPR allows exploration of disease in every cell type
2 December 2016 | By Niamh Louise Marriott, Digital Editor
These systems will allow researchers worldwide to rapidly and accurately explore the changing role of genes as the cells develop into tissues...
news
Charles River demonstrates CRISPR/Cas9 genome engineering expertise
2 December 2016 | By Charles Rivers Laboratories
Charles River Laboratories has launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology...
news
TSRI scientists develop vaccine against fatal prescription opioid overdose
30 November 2016 | By Niamh Louise Marriott, Digital Editor
Scientists at The Scripps Research Institute have developed a vaccine that blocks the pain-numbing effects of the opioid drugs in animal models...
whitepaper
App note: Evaluation of RNA isolation efficiency of Pall AcroPrep™ Advance 96-Well Long Tip Filter Plate for Nucleic Acid Binding
In this application note, Pall Laboratory evaluate the performance of the Pall AcroPrep Advance 96-Well Filter Plates for Nucleic Acid Binding (Pall NAB plate), which contain a silica-based quartz glass fiber media for the isolation of total RNA...
article
C is for CRISPR
16 November 2016 | By Niamh Louise Marriott, Digital Content Producer
C is for CRISPR - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research of CRISPR technology
news
3D printed customised insoles for diabetes patients
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In the past, insoles for patients with diabetes were hand-made by orthopaedic shoemakers. In the future, these specialist shoemakers will be able to produce insoles more cost-effectively thanks to new software and the use of 3D printers. This approach means the mechanical properties of each insole can be assessed scientifically…
news
€3.2 million grant for medical fibre optics research
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The fibre optics research at KTH covers everything from bio-implants via medical sensors to solar cells and the researchers aim to have developed several...
news
Artes and BioSun to co-develop on HPV vaccine
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The agreed long-term collaboration will take strengths from both companies to collaborate on the HPV vaccine although financial details of this agreement...
news
€3.3 million to improve medical imaging detail tenfold
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A recent investment of €3.3 million will allow researchers to improve the detail of medical imaging ten times over, which will allow for tumour scanning...
